| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13419* | 2021 |
| Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH S Bekri, P Gual, R Anty, N Luciani, M Dahman, B Ramesh, A Iannelli, ... Gastroenterology 131 (3), 788-796, 2006 | 644 | 2006 |
| Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation S Bekri, G Kispal, H Lange, E Fitzsimons, J Tolmie, R Lill, DF Bishop Blood, The Journal of the American Society of Hematology 96 (9), 3256-3264, 2000 | 304 | 2000 |
| Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation C Brasse–Lagnel, Z Karim, P Letteron, S Bekri, A Bado, C Beaumont Gastroenterology 140 (4), 1261-1271. e1, 2011 | 280 | 2011 |
| The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH R Anty, S Bekri, N Luciani, MC Saint-Paul, M Dahman, A Iannelli, IB Amor, ... Official journal of the American College of Gastroenterology| ACG 101 (8 …, 2006 | 230 | 2006 |
| Omics-based strategies in precision medicine: toward a paradigm shift in inborn errors of metabolism investigations A Tebani, C Afonso, S Marret, S Bekri International journal of molecular sciences 17 (9), 1555, 2016 | 199 | 2016 |
| Disruption of autophagy at the maturation step by the carcinogen Lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal–regulated kinase … E Corcelle, M Nebout, S Bekri, N Gauthier, P Hofman, P Poujeol, ... Cancer research 66 (13), 6861-6870, 2006 | 197 | 2006 |
| Detailed map of a region commonly amplified at 11q13→ q14 in human breast carcinoma S Bekri, J Adelaide, S Merscher, J Grosgeorge, F Caroli-Bosc, ... Cytogenetic and Genome Research 79 (1-2), 125-131, 1997 | 194 | 1997 |
| Porphyria cutanea tarda and antibodies to hepatitis C virus JP Lacour, I Bodokh, J Castanet, S Bekri, JP Ortonne British Journal of Dermatology 128 (2), 121-123, 1993 | 151 | 1993 |
| Autophagosome maturation is impaired in Fabry disease M Chévrier, N Brakch, L Céline, D Genty, Y Ramdani, S Moll, ... Autophagy 6 (5), 589-599, 2010 | 132 | 2010 |
| Clinical metabolomics: the new metabolic window for inborn errors of metabolism investigations in the post-genomic era A Tebani, L Abily-Donval, C Afonso, S Marret, S Bekri International journal of molecular sciences 17 (7), 1167, 2016 | 128 | 2016 |
| Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B‐cell malignancies SD Raynaud, S Bekri, D Leroux, J Grosgeorge, B Klein, C Bastard, ... Genes, Chromosomes and Cancer 8 (2), 80-87, 1993 | 118 | 1993 |
| Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease N Brakch, O Dormond, S Bekri, D Golshayan, M Correvon, L Mazzolai, ... European heart journal 31 (1), 67-76, 2010 | 113 | 2010 |
| Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgia C Michot, L Hubert, NB Romero, A Gouda, A Mamoune, S Mathew, E Kirk, ... Journal of inherited metabolic disease 35, 1119-1128, 2012 | 109 | 2012 |
| Paving the way to precision nutrition through metabolomics A Tebani, S Bekri Frontiers in nutrition 6, 41, 2019 | 107 | 2019 |
| Clinical results of enzyme replacement therapy in Fabry disease: a comprehensive review of literature O Lidove, D Joly, F Barbey, S Bekri, JF Alexandra, V Peigne, R Jaussaud, ... International journal of clinical practice 61 (2), 293-302, 2007 | 95 | 2007 |
| Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation R Anty, M Dahman, A Iannelli, P Gual, A Staccini-Myx, IB Amor, N Luciani, ... Obesity surgery 18, 709-714, 2008 | 87 | 2008 |
| The role of ceramide trihexoside (globotriaosylceramide) in the diagnosis and follow-up of the efficacy of treatment of Fabry disease: a review of the literature S Bekri, O Lidove, R Jaussaud, B Knebelmann, F Barbey Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly …, 2006 | 80 | 2006 |
| Fabry disease in patients with end-stage renal failure: the potential benefits of screening S Bekri, A Enica, T Ghafari, G Plaza, I Champenois, G Choukroun, ... Nephron Clinical Practice 101 (1), c33-c38, 2005 | 79 | 2005 |
| Fatal rhabdomyolysis in 2 children with LPIN1 mutations J Bergounioux, A Brassier, C Rambaud, O Bustarret, C Michot, L Hubert, ... The Journal of pediatrics 160 (6), 1052-1054, 2012 | 69 | 2012 |
